Evidence map›Paper›PMID 34341497›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

BDNF controls GABA

Toshifumi Tomoda, Akiko Sumitomo, Rammohan Shukla, Yuki Hirota-Tsuyada, Hitoshi Miyachi, Hyunjung Oh, Leon French, Etienne Sibille

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Regulating the crosstalk betweenFrontiers in immunology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Toshifumi TomodaCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. Toshifumi.Tomoda@camh.ca.
Akiko SumitomoCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Rammohan ShuklaCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Yuki Hirota-TsuyadaDepartment of Research and Drug Discovery, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hitoshi MiyachiInstitute for Virus Research, Kyoto University, Kyoto, Japan.
Hyunjung OhCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Leon FrenchCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Etienne SibilleCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. Etienne.Sibille@camh.ca.ORCID http://orcid.org/0000-0001-5832-6570
Centre for Addiction and Mental Health · CAKyoto University · JP

Funding

Molecular Aging of the Human Brain: Genetic Modulation and Functional OutcomesR01MH093723 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIBILLE, ETIENNE L · 2011 to 2015
$2.6M
CIHR 153175NIMH NIH HHS R01 MH093723
6 · The paper itself

Abstract

Reduced brain-derived neurotrophic factor (BDNF) and gamma-aminobutyric acid (GABA) neurotransmission co-occur in brain conditions (depression, schizophrenia and age-related disorders) and are associated with symptomatology. Rodent studies show they are causally linked, suggesting the presence of biological pathways mediating this link. Here we first show that reduced BDNF and GABA also co-occur with attenuated autophagy in human depression. Using mice, we then show that reducing Bdnf levels (Bdnf

Indexed as

Brain-Derived Neurotrophic Factorgamma-Aminobutyric AcidAnimalsAutophagyCognitionMiceReceptors, GABA-ASequestosome-1 ProteinSynaptic TransmissionBdnf protein, mouseBrain-Derived Neurotrophic Factorgamma-Aminobutyric AcidReceptors, GABA-ASequestosome-1 Protein

Identifiers

PMID34341497
PMCPMC8674239
OpenAlexW3188700951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.